NVAX240719C17000
- 0.52
- +0.23+79.31%
Novavax Newsroom
$100 Invested In This Stock 5 Years Ago Would Be Worth $400 Today
Novavax (NASDAQ:NVAX) has outperformed the market over the past 5 years by 15.36% on an annualized basis producing an average annual return of 29.01%. Currently, Novavax has a market capitalization
UnitedHealth Posts Better-Than-Expected Earnings, Joins AngioDynamics, Bank of America And Other Big Stocks Moving Higher On Tuesday
U.S. stocks were mostly higher, with the Dow Jones index gaining around 550 points on Tuesday.Shares of UnitedHealth Group Incorporated (NYSE:UNH) rose sharply during Tuesday's session following a
Novavax, Inc. (NVAX) Is Attracting Investor Attention: Here Is What You Should Know
Novavax Options Spot-On: On July 15th, 69,528 Contracts Were Traded, With 392.8K Open Interest
On July 15th ET, $Novavax(NVAX.US)$ had active options trading, with a total trading volume of 69,528 options for the day, of which put options accounted for 10.44% of the total transactions, and
What's Going On With Novavax Shares Monday?
Novavax, Inc. (NASDAQ:NVAX) shares are moving higher on Monday. Here's what you need to know.What To Know: The company announced on July 2 that it has filed for authorization with Health Canada for
Wall Street Bulls Look Optimistic About Novavax (NVAX): Should You Buy?
Does Novavax's (NASDAQ:NVAX) Pullback Could Signal a Buying Opportunity
Express News | State Street Corp Reports 4.32% Passive Stake in Novavax Inc as of June 30, 2024 Vs 12.11% as of April 30, 2023 - SEC Filing
Novavax (NVAX) Exceeds Market Returns: Some Facts to Consider
Investors Push Novavax (NASDAQ:NVAX) 6.0% Lower This Week, Company's Increasing Losses Might Be to Blame
After falling to an 11-year low and consolidating for several months, should I buy or sell pfizer (PFE.US) now?
In April of this year, Pfizer's (PFE.US) stock price fell to its lowest point since January 2013. As of the closing of July 1st, the stock has risen by about 11% since then; after falling to an 11-year low, Pfizer has been in a consolidation phase for several months. So, should you sell or buy Pfizer stocks now? From a fundamental perspective, Pfizer is still trying to overcome the drag of the cooling of its COVID-19 product and pushing forward the development of non-COVID-19 drug businesses. Recently, the company announced positive results from trials of two cancer drugs, but also closed a gene therapy program, and its stock price continues to range. In a study, patients received Pfizer's Elrex
(NVAX) - Analyzing Novavax's Short Interest
Novavax's (NYSE:NVAX) short percent of float has risen 3.9% since its last report. The company recently reported that it has 39.71 million shares sold short, which is 34.36% of all regular shares that
COVID Infections Could Be Seeing a Summer Surge Based on CDC Data
Express News | Novavax Inc - Intends to Have Its Vaccine Available in Canada for Immediate Release Post-Authorization
Express News | Novavax Submits Application to Health Canada for Updated Protein-Based 2024-2025 Formula Covid-19 Vaccine
Novavax Submits Application to Health Canada for Updated Protein-based 2024-2025 Formula COVID-19 Vaccine
Novavax's COVID-19 vaccine would be the only protein-based option available in Canada, if authorizedNovavax's filing is aligned with NACI, U.S. FDA, EMA and WHO recommendations on vaccine compositionG
Jim Cramer Says You Should Not Buy Novavax Inc (NASDAQ:NVAX)
Where Will Novavax Be in 1 Year?
Novavax (NVAX) Falls More Steeply Than Broader Market: What Investors Need to Know
Express News | U.S. Cdc: Updated 2024-2025 Flu Vaccines Will All Be Trivalent and Will Protect Against an H1N1, H3N2 and a B/Victoria Lineage Virus